1. Home
  2. VRA vs PRLD Comparison

VRA vs PRLD Comparison

Compare VRA & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.20

Market Cap

60.6M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$2.77

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
PRLD
Founded
1982
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
69.1M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
VRA
PRLD
Price
$3.20
$2.77
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.00
$4.00
AVG Volume (30 Days)
1.1M
495.7K
Earning Date
12-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
$10,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
250.00
52 Week Low
$1.39
$0.61
52 Week High
$4.00
$4.22

Technical Indicators

Market Signals
Indicator
VRA
PRLD
Relative Strength Index (RSI) 71.33 63.48
Support Level $2.10 $2.37
Resistance Level $2.50 $3.00
Average True Range (ATR) 0.18 0.28
MACD 0.11 0.03
Stochastic Oscillator 99.79 76.55

Price Performance

Historical Comparison
VRA
PRLD

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: